Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ONL-1204 by ONL Therapeutics for Geographic Atrophy: Likelihood of Approval
ONL-1204 is under clinical development by ONL Therapeutics and currently in Phase I for Geographic Atrophy. According to GlobalData, Phase...
ONL-1204 by ONL Therapeutics for Retinal Pigment Epithelial (RPE) Detachment: Likelihood of Approval
ONL-1204 is under clinical development by ONL Therapeutics and currently in Phase II for Retinal Pigment Epithelial (RPE) Detachment. According...
ONL-1204 by ONL Therapeutics for Retinal Pigment Epithelial (RPE) Detachment: Likelihood of Approval
ONL-1204 is under clinical development by ONL Therapeutics and currently in Phase II for Retinal Pigment Epithelial (RPE) Detachment. According...